KannaLife Sciences Inc. will continue to breathe new life to pharmacological products this year through research and development, as they had recently received Series A financing amounting to $1.5 million.

The company’s Founder and Chief Executive Officer Dean Petkanas shares more about this recent achievement in this e-interview with Lead411: